Records show that Cercle Allocation Services billed a UCLA research operation $765 for each liver or thymus specimen, describing the charges as procurement service fees. The paperwork matters because federal law prohibits transferring human fetal tissue for valuable consideration, while allowing reasonable payments for related services; the records alone do not establish that any law was broken.

Two purchase orders list seven specimens totalling $5,355 and five specimens totalling $3,825, with the same per-specimen charge. Cercle asked UCLA to remove sales-tax wording, saying it could suggest the tissue itself was being sold, and UCLA revised purchase orders after the objection. The records do not identify the specimens as fetal, and Fox News Digital said it could not independently verify that they were; the company’s involvement in fetal-tissue procurement is separately described in scientific literature.